Luminol-enhanced chemiluminescence for evaluation of type III group B streptococcal opsonins in human sera

The Journal of Infectious Diseases
D C AndersonC J Baker

Abstract

A luminol-enhanced chemiluminescence (CL) assay was developed to evaluate type III group B streptococcal opsonins. Sera from 11 adults that contained high (greater than 25 microgram/ml), intermediate (3-24 microgram/ml), or low (less than 2 microgram/ml) antibody concentrations were assessed by CL, indirect immunofluorescence (IF), and bactericidal assays. Total CL activity correlated with antibody concentration (P less than 0.005), IgG- and C3-IF values, and phagocytic and bactericidal indices. Heat-stable CL activity correlated with antibody concentration (P less than 0.0001) and was related to IgG-IF values and phagocytic indices. Significant bactericidal activity was demonstrated in all sera containing greater than 2 microgram of antibody/ml, but no bactericidal activity was observed in heat-inactivated sera. Adsorption of heated sera with type III group B Streptococcus abolished CL activity, whereas CL values of MgEGTA-chelated sera were approximately 80% of untreated sera. Thus, type-specific antibody in addition to heat-labile serum factors, including those of the alternative complement pathway, contribute to opsonization of type III group B Streptococcus.

Citations

Nov 1, 1987·Journal of Clinical Immunology·S Bender, S Hetherington
Jun 1, 1982·Klinische Wochenschrift·J E MenitoveR H Aster
Jan 1, 1985·Developmental and Comparative Immunology·A L ScottP H Klesius
Mar 12, 1981·The New England Journal of Medicine·J D Siegel, G H McCracken
Apr 1, 1995·Acta Paediatrica Japonica; Overseas Edition·A NishidaM Nakano
Apr 16, 1998·Archives of Disease in Childhood. Fetal and Neonatal Edition·J KällmanE Kihlström
Jun 1, 1983·Current Problems in Pediatrics·K L CatesM Ballow
May 8, 1997·British Journal of Nursing : BJN·B Greatrex
Dec 1, 1985·Acta Pathologica, Microbiologica, Et Immunologica Scandinavica. Section C, Immunology·C SöderströmA G Sjöholm
Dec 1, 1995·Infection and Immunity·S TakahashiY Okuwaki
Mar 1, 1981·Journal of Clinical Microbiology·S L KaplanR D Feigin
Oct 1, 1987·Infection and Immunity·K M ButlerM S Edwards
Feb 1, 1984·Infection and Immunity·M F TosiD C Anderson
Aug 1, 1984·Clinical Immunology and Immunopathology·T MeshulamJ D Sobel

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antibody-Dependent Cell Cytotoxicity

Antibody-dependent cellular toxicity refers to the lysis of a target cell by a non-sensitized effector cell of the immune system as a result of antibodies binding to the target cell membrane and engaging the Fc receptors on the immune effector cells. Find the latest research on antibody-dependent cellular toxicity here.

Alternative Complement Pathway

The Alternative Complement Pathway is part of the innate immune system, and activation generates membrane attack complexes that kill pathogenic cells. Discover the latest research on the Alternative Complement Pathway.